Lab Analyzers - Immunoassay: Market Size & Forecast 2026

The global immunoassay analyzers market sits at approximately USD 5.8 billion in 2025 (base year), expanding at a 5.2% CAGR through 2032 to roughly USD 8.2 billion. Demand-supply is in a balanced-to-tight state, with recurring reagent revenue (38% of unit cost on a reference SKU) anchoring the commercial model while instrument capital remains the procurement-cycles lever. The dominant near-term inflections are IVDR-driven CE-mark renewal under Regulation (EU) 2017/746, the BD-to-Waters USD 3.5B diagnostics divestiture closing the year, and clinical-lab automation expansion across APAC hospital networks. > **Analyst Take. Our view: the next 24 months reward procurement leaders who lock multi-year reagent agreements before the IVDR-driven re-certification wave compresses supplier flexibility. Buyers anchored to annual reagent renewals will see 6-10% price escalation (method: observed IVDR-

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.